Pulmonx Share Price Today
(NASDAQ: LUNG)

Name: Pulmonx Share Price Today (NASDAQ: LUNG) - Pulmonx Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Pulmonx share price is $8.19 & ₹712.28 as on 6 Mar 2025, 2.30 'hrs' IST

$8.19

▲

-0.48

(-5.54%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Pulmonx share price in Dollar and Rupees. Guide to invest in Pulmonx stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pulmonx, along with analyst recommendations, forecasts, and comprehensive financials.

Pulmonx share price movements

Today's Low: $8.11
Today's High: $8.71
$8.19
0.98%
Downside
Day's Volatility :6.86%
Upside
5.94%
52 Weeks Low: $5.46
52 Weeks High: $10.01
$8.19
33.33%
Downside
52 Weeks Volatility :45.45%
Upside
18.18%

Pulmonx (LUNG) Returns

Period	Pulmonx Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	40.75%	2.1%	0.0%
6 Months	24.93%	-4.1%	0.0%
1 Year	-2.03%	2.2%	0.0%
3 Years	-59.6%	11.8%	-11.6%

Pulmonx (LUNG) Key Statistics

in dollars & INR

Previous Close	$8.67
Open	$8.65
Today's High	$8.707
Today's Low	$8.11
Market Capitalization	$345.0M
Today's Volume	$146.5K
52 Week High	$10.01
52 Week Low	$5.46
Revenue TTM	$83.8M
EBITDA	$-54.5M
Earnings Per Share (EPS)	$-1.5
Profit Margin	-67.31%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-55.26%

How to invest in Pulmonx Stock (LUNG) from India?

It is very easy for Indian residents to invest directly in Pulmonx from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pulmonx stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pulmonx or LUNG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pulmonx or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pulmonx shares which would translate to 0.106 fractional shares of Pulmonx as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pulmonx, in just a few clicks!

Returns in Pulmonx (LUNG) for Indian investors in Rupees

The Pulmonx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Pulmonx investment value today

Current value as on today

₹97,505

Returns

₹2,495

(-2.49%)

Returns from Pulmonx Stock

₹7,458 (-7.46%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Pulmonx (LUNG)

-11%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Pulmonx Stock from India on INDmoney has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Pulmonx

FMR Inc
14.88%
PRIMECAP Management Company
13.85%
Morgan Stanley - Brokerage Accounts
7.72%
BlackRock Inc
7.16%
Vanguard Group Inc
5.74%
Deerfield Management Co
3.86%

Analyst Recommendation on Pulmonx

Buy

81%Buy

18%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Pulmonx(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Pulmonx Stock (LUNG)

What analysts predicted

Upside of 42.45%

Target:

$11.67

Current:

$8.19

Insights on Pulmonx Stock (Ticker Symbol: LUNG)

Price Movement
In the last 1 month, LUNG stock has moved up by 41.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 20.38M → 23.76M (in $), with an average increase of 14.2% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -15.32M → -13.17M (in $), with an average increase of 7.9% per quarter
LUNG vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 54.6% return, outperforming this stock by 58.3%
LUNG vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 135.7% return, outperforming this stock by 197.6%
Price to Sales
ForLUNG every $1 of sales, investors are willing to pay $4.0, whereas for Boston Scientific Corp., the investors are paying $9.1 for every $1 of sales.

Pulmonx Technicals Summary

Sell

Neutral

Buy

Pulmonx is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Pulmonx (LUNG) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Pulmonx Corp	50.26%	24.93%	-2.03%	-59.6%	-77.94%
Medtronic Plc	2.26%	4.07%	8.74%	-12.76%	0.68%
Edwards Lifesciences Corp.	0.07%	8.12%	-19.19%	-34.12%	12.08%
Boston Scientific Corp.	0.07%	27.33%	53.68%	143.5%	203.93%
Stryker Corporation	-0.63%	8.92%	9.84%	53.87%	125.87%
Abbott Laboratories	7.11%	21.64%	15.28%	15.75%	78.63%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Pulmonx Corp	NA	NA	NA	-1.54	-0.55	-0.21	NA	2.16
Medtronic Plc	28.75	28.75	1.87	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	30.5	30.5	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	83.9	83.9	1.85	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.89	50.89	2.85	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Pulmonx Corp	Buy	$345.0M	-77.94%	NA	-67.31%
Medtronic Plc	Buy	$120.9B	0.68%	28.75	12.83%
Edwards Lifesciences Corp.	Buy	$42.0B	12.08%	30.5	76.75%
Boston Scientific Corp.	Buy	$154.8B	203.93%	83.9	11.07%
Stryker Corporation	Buy	$150.7B	125.87%	50.89	13.25%
Abbott Laboratories	Buy	$238.6B	78.63%	18.34	31.95%

About Pulmonx

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Organization	Pulmonx
Employees	291
CEO	Mr. Steven S. Williamson
Industry	Health Technology

Management People of Pulmonx

Name	Title
Mr. David A. Lehman J.D.	General Counsel & Secretary
Mr. Geoffrey Beran Rose	Chief Commercial Officer
Mr. Steven S. Williamson	CEO, President & Director
Mr. Mehul Joshi	Chief Financial Officer
Mr. Sri Radhakrishnan	Chief Technical Officer
Ms. Lauren Cristina	Vice President of Finance & Administration (U.S.)
Ms. Marcee M. Maroney	Vice President of Marketing
Ms. Sarah Huber	Vice President of Sales (U.S.)
Ms. Lisa Paul	Chief People Officer
Mr. Jérôme Erath	Senior VP & GM of Europe Middle-East & Africa

Important FAQs about investing in LUNG Stock from India :

What is Pulmonx share price today?

Pulmonx share price today stands at $8.19, Open: $8.65 ; Previous Close: $8.67 ; High: $8.71 ; Low: $8.11 ; 52 Week High: $10.01 ; 52 Week Low: $5.46.

The stock opens at $8.65, after a previous close of $8.67. The stock reached a daily high of $8.71 and a low of $8.11, with a 52-week high of $10.01 and a 52-week low of $5.46.

Can Indians buy Pulmonx shares?

Yes, Indians can invest in the Pulmonx (LUNG) from India.

With INDmoney, you can buy Pulmonx at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Pulmonx at zero transaction cost.

How can I buy Pulmonx shares from India?

It is very easy to buy Pulmonx from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pulmonx (LUNG) be purchased?

Yes, you can buy fractional shares of Pulmonx with INDmoney app.

What are the documents required to start investing in Pulmonx stocks?

To start investing in Pulmonx, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.